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Signs and Symptoms 
 
• Signs and symptoms of gout start with an elevation in 
serum uric acid levels greater than 6.8 mg/dl.   
• Four clinical manifestations are seen in gout:  
asymptomatic hyperuricemia, acute gout, intercritical 
gout, and chronic advanced gout.   
• Symptoms occur when elevated uric acid in the 
bloodstream creates urate crystals triggering a gout 
flare.   
• A flare is an acute onset within 24 hours with extremely 
painful mono or oligoarthritis, which often results in sick 
leave.  
• Higher uric acid levels predict more flares and 
development of tophi.  Tophi are an accumulation of 
monosodium urate crystals that can form swollen areas 
in the joints, cartilage, bones, and skin nodules.  
• Hyperuricemia can be non-symptomatic but typically 
precedes gout.   
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Introduction 
 
Gout is a syndrome caused by an inflammatory response 
creating an over production of uric acid increasing uric acid 
levels in the blood and body fluids.  Gout is defined as a 
disorder resulting from tissue deposition of MSU crystals 
(in joints, bursae, bone, and certain other soft tissues, such 
as ligaments, tendons and occasionally, skin) and/or 
crystallization of uric acid within the renal collecting 
system (tubules and renal pelvis) that typically occurs in 
acid urine” (Terkeltaub & Edwards, 2013, p. 20).  Gout is 
among the oldest diseases affecting approximately 3.9% of 
adults in America (Terkeltaub & Edwards, 2013, p. xv).  
Historically, Gout was the “disease of kings.”  An early 
century caricature depicts gout in affluent middle-aged 
men that over indulge in alcohol and food.  Today, the 
population stereotypes the average patient with 
impressions of self-limiting behavior such as drinking and 
diet (Terkeltaub & Edwards, 2013, p. xv). Gout prevalence 
and incidence are on the rise.  Gout pathophysiology is 
complex and not easily understood affecting the patients’ 
quality of life. Gout treatment is associated with treatment 
failure and noncompliance. Consequently, “Most patients 
with gout are treated in general practice and never enter 
the domain of the rheumatologist, and general 
practitioners (GPs) are unlikely to read guidelines that are 
published in rheumatology journals or present on 
rheumatology websites” (Perry & Madhok, 2010, p. 2233). 
Increasing knowledge and understanding of gout, clinicians 
can significantly influence the quality of life through 
treatment options for patients and practitioners.  
Underlying Pathophysiology 
 
Symptoms occur when elevated uric acid in the bloodstream 
creates urate crystals that deposit in the joints or tendons causing 
inflammation.  Inflammatory cytokines and neutrophils trigger by 
the immune response from crystal deposits in the joints.  “MSU 
crystals deposit into tophi typically in cool, poorly vascularized 
peripheral connective tissue” (Terkeltaub & Edwards, 2013, p. 43) 
Uric acid is the byproduct of purine catabolism generated from 
the activity of xanthine oxidase (Zychowicz, Pope, & Graser, 2010, 
p. 624).  Purines are chemicals found in the human body obtained 
through the diet.  “Evolutionary loss of functional uricase, the 
enzyme that converts uric acid to the more soluble allantoin in 
most other mammals, causes hyperuricemia risks in humans” 
(Zychowicz et al., 2010, p. 624).  Hyperuricemia occurs from an 
overproduction of uric acid (10%) or urate under-excretion (90%) 
by the kidneys.  Inherited mutations in renal urate transporters, 
acquired kidney disease, hypertension, insulin resistance 
(metabolic syndrome), high alcohol intake, lead toxicity, 
medications are contributing factors to inefficient renal excretion 
of uric acid (Terkeltaub & Edwards, 2013, table 1.3).  Genetic 
disorders, disorders of increased cell turnover, and diet result in 
overproduction of uric acid (Terkeltaub & Edwards, 2013, table 
1.3). The clinical presentation of gout is monoarticular pain and 
swelling in the lower extremities especially the great toe.  Patients 
complain of symptoms more often at night with a duration of 3 to 
10 days before seeking treatment (Hardy, 2011, p. 14). Treatment 
goals are to reduce gout flare, protect against future attacks, and 
lower serum urate. 
 
  
Significance of Pathophysiology 
 
Asymptomatic Hyperuricemia 
Hyperuricemia can be non-symptomatic but typically precedes 
gout.  Asymptomatic gout is associated with lower uric acid levels. 
Asymptomatic gout is the elevation of uric acid in the blood with 
no clinical symptoms.  Silent tissue deposits of urate may be 
present.  Gout affects the lower extremities often at night and may 
present as an itchy feeling. 
  
Acute Intermittent Gout 
Acute gout attacks are usually sudden, nocturnal and triggered by 
alcohol intake, dehydration, joint injury recent surgery, and fever.   
Acute gout treatments priority is to relieve the acute symptoms by 
reducing inflammation and reducing serum urate.  Medications 
include NSAIDS, oral colchicine, and corticosteroids.  
The classic presentation is podagra, 90% of patient have this 
inflammation of the first metatarsophalangeal joint of the foot.   
Lower extremity joints are most common for initial gout attacks.  
Acute gouty arthritis results from increased uric acid levels that 
cause monosodium urate crystals (MSU) to deposit in the joints.  
MSU attract leukocytes to the synovial space where the MSU 
crystals get phagocytized and destructive enzymes cause further 
inflammation and tissue damage (Hardy, 2011, p. 14).  
Patients may have systemic symptoms such as low grade fever, 
chills, and malaise.  Laboratory data may reveal elevated 
sedimentations rate and leukocytosis.  
Intercritical gout is when acute gouty arthritis returns to an 
asymptomatic phase.  
 
Advanced Gout 
Untreated gout will progress to advanced gout.  Intercritical 
periods disappear and patient develops chronic arthritis due to 
tophi causing synovial inflammation making joints painful and 
swollen.  Chronic tophaceous gout is a cycle of attacks that over 
time, attacks will occur more frequently, affect more joints and last 
longer.  “Some 60% of patients will have a second attack in the first 
year, and 78% will have a second attack within two years” (Hardy, 
2011, p. 14) 
 
 
 
 
 
 
 Implications for Nursing Care 
 
 
• Patients with gout show reduced health related quality of life exhibit reduced social 
functioning due to pain, limited activity, and immobility.  Quick treatment of acute gout 
flares and prevention of subsequent attacks is essential, “subjects perception of their 
overall gout related pain and functioning were highly correlated with HRQOL and 
disability” (Smith, Bracken, & Smith, 2011, p. 1114). 
 
• Improving outcomes in the management of gout necessitates the nurse to become 
knowledgeable of the stages of gout including treatment goals and treatment 
complications.  Nursing strategies includes detecting risk factors, identifying predisposing 
factors, and recognizing symptoms. Nurses educate patients on acute attacks, preventing 
attacks, dietary modification, and general considerations of gout through all four stages.  
Gout is on the rise and affects approximately 3 to 5 million people in the United States 
(Hardy, 2011, p. 14).  Due to the sporadic nature of gout, identifying risk factors is essential 
to improving outcomes.  
 
• Risk factors include advanced age, male gender, postmenopausal female gender, drugs 
(diuretics, low-dose aspirin, cyclosporine), hypertension, high alcohol intake, high body 
mass index, diet high in meat and seafood, and genetic influences (Vannucchi, 2012).  With 
only “approximately 20% of patients will make lifestyle changes” (Hardy, 2011, p. 19), 
increasing the need for nurses to education about joint destruction during the intercritical 
periods is critical.  Advance practice nurses identify that gout may be a sign of other 
comorbidities such as diabetes mellitus, hypertension, renal manifestations, obesity, 
metabolic syndrome, heart failure, hyperlipidemia, and cardiovascular disease. 
  
• Rheumatologists are specialist trained in the acute and chronic management of gout.  
Hardy (2011) states that studies show that gout is a common cause for inpatient 
rheumatologist referrals, and primary care physicians refer only 3% of patients to a 
rheumatologist (p. 19).  The American College of Rheumatology established treatment 
guidelines to set a standard for the treatment of gout.  Crittenden & Pillinger (2013) 
identify gout treatment guidelines including dietary considerations, treatment of acute 
gout attacks, lowering urate in established gout patient, preventative treatment, and 
seeking expert guidance.  Non-pharmacological treatment of gout includes applying ice and 
resting the joints.  
 
• Pharmacologic treatment includes non-steroidal anti-inflammatory drugs, urate lower 
drugs, glucocorticoids, intra-articular steroid with careful consideration to coexisting illness 
and severity of symptoms.  Advanced practice nurses educate and monitor the gout patient 
for adverse side effects associated with gout treatment.  Key strategies focus on mediation 
compliance, potential side effects, and contraindications.   
 
Conclusion 
 
Gout tends to be undertreated and on the rise.  Poor patient understanding, physician failure to 
develop targeted treatment plans, and failure of therapies are reasons for inadequate gout 
treatments.  Nurses play a significant role in improving outcomes for the identification and 
management of gout through education, collaboration, and compliance.  Gout patients add 
significantly to national health care costs in gout patients with more frequent attack.  Acute gout 
symptoms encourage patients to seek treatment due to pain.  Intercritical periods reduce 
medication compliance and dietary management resulting in increased risk of tophi development 
and acute gouty attacks.  Routine follow up is essential to achieve treatment goals. Nurses 
sensitize the patient on the lifelong compliance of urate-lowering medications, dietary 
restrictions, and the importance of maintaining a healthy weight through diet and exercise.  
Nurses are essential to improve the patients’ quality of life but also improving utilization of 
health care resources.  
Clinical example excision of 
gouty tophi 
